Dr. Colm Henry:

On the breast clinic, every screening programme has two sides. There is the screening itself and what that leads to for those for whom there are findings. We have seen increased demands in the breast screening programme since 2019 and increased recall rate. We have seen a big increase in the recall rate, in the order of 30% to 40%, driven not just by demographics but different technologies and perhaps in some ways a more cautious approach in some interpretations of the mammograms. That means that we have had to invest in and link with those centres, because screening programmes must link to treatment centres, which are the symptomatic breast clinics, to ensure that once we identify an abnormality, any time waiting to attend a symptomatic breast clinic and get additional investigations is minimised. We watch that closely.